Kate Farms vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 52)
Kate Farms logo

Kate Farms

ChallengerHealthcare

Plant-Based Medical Nutrition & Tube Feeding

Kate Farms makes the only organic, plant-based tube feeding formulas using hydrolyzed pea protein; covers pediatric and adult patients across standard and peptide formulas, broadly covered by insurance, with McKesson distribution.

AI VisibilityBeta
Overall Score
C52
Category Rank
#315 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
54
Gemini
51

About

Kate Farms is a medical nutrition company that develops and markets organic, plant-based enteral (tube feeding) formulas for adults and children who require nutritional support via feeding tubes or oral supplementation. Founded after co-founder Richard Lyman sought a dairy-free, plant-based alternative for his daughter Kate — who had Angelman syndrome and cerebral palsy — the company''s products are designed for improved tolerance compared to corn-syrup and dairy-based legacy formulas. Kate Farms formulas use organic pea protein, phytonutrients, prebiotic fiber, and a clean ingredient list that excludes dairy, soy, gluten, corn, and nuts.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

52
Overall Score
93
#315
Category Rank
#1
74
AI Consensus
80
stable
Trend
stable
57
ChatGPT
94
54
Perplexity
89
51
Gemini
94
57
Claude
92
47
Grok
98

Key Details

Category
Plant-Based Medical Nutrition & Tube Feeding
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.